Chu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) reviews of
randomized controlled trials found insufficient evidence to guide practice, but most excluded
Agaverdiev, Murad,
Shamsov, Bedil,
Mirzoev, Sorbon,
Vardikyan, Andranik,
Encarnacion, Manuel Ramirez,
Nurmukhametov, Renat,
Beilerli, Aferin,
Zhang, Bohan,
Gareev, Ilgiz,
Pavlov, Valentin (2023) into two stages.
Results: By August 2022, there were 149 registered clinical
trials. Most studies belong
The relevance of the chosen
topic is due to the need to introduce modern digital tech
, therapeutic approaches that target both diseases are needed. Clinical
trials are currently underway to explore